SCHEMBL29846973

SCHEMBL29846973

CC(c1cc(C(F)(F)F)ccc1F)N1CCc2ncccc2C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 4/20 0.38
▸ KCNN4 O15554 4/20 0.37
▸ TRPV1 Q8NER1 1/20 0.37
▸ NPC1 O15118 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ PDE2A O00408 2/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ CCNB2 O95067 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CCNB1 P14635 1/20 0.34
▸ GSK3B P49841 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ CCNB3 Q8WWL7 1/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ CYP3A5 P20815 2/20 0.34
▸ PSEN1 P49768 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29846888 0.85 NPC1 (0.39) GRM5KCNN4TRPV1NPC1TP53
SCHEMBL23753939 0.84 KCNN4 (0.36) KCNN4PDE2ACYP3A4CYP3A5PSEN1
SCHEMBL29847242 0.84 KCNN4 (0.36) KCNN4PDE2ACYP3A4CYP3A5PSEN1
SCHEMBL29847281 0.78 TRPV1 (0.37) GRM5KCNN4TRPV1NPC1TP53
SCHEMBL29847259 0.77 GRM5 (0.41) GRM5TRPV1NPC1TP53MAPT
SCHEMBL21144746 0.74 GRM5 (0.60) GRM5NPC1TP53MAPTRAB9A
SCHEMBL29847015 0.73 PIK3CG (0.37) KCNN4
SCHEMBL23753819 0.73 PIK3CG (0.37) KCNN4
SCHEMBL30130627 0.71 CHRM1 (0.45) GRM5
SCHEMBL23753929 0.69 PDE2A (0.33) PDE2APSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4105216-B1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF GENFLEET THERAPEUTICS SHANGHAI INC (CN) 2026-05-20 — — EP disclosed
CN-115135648-B Dihydronaphthyridones, preparation method and medical application thereof 劲方医药科技(上海)有限公司 2024-02-09 — — CN disclosed
US-20230139111-A1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) 2023-05-04 — — US disclosed
EP-4105216-A1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Genfleet Therapeutics (Shanghai) Inc. (CN) 2022-12-21 — — EP disclosed
CN-115135648-A Dihydronaphthyridinone compounds, preparation method and medical application thereof 劲方医药科技(上海)有限公司 2022-09-30 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139111-A1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF RIPK1, RIPK4, RIPK3 GRM5 2262/4885KCNN4 3903/4885TRPV1 1070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback